Back
Oppenheimer Holdings 10K Form
Buy
63
OPY
Oppenheimer Holdings
Last Price:
$62.19
Seasonality Move:
10.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2024-03-01 | 10K | OPY/Oppenheimer Holdings Annual |
2023-10-27 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-07-28 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-04-28 | 10Q | OPY/Oppenheimer Holdings Quarterly |
2023-03-03 | 10K | OPY/Oppenheimer Holdings Annual |
Receive OPY News And Ratings
See the #1 stock for the next 7 days that we like better than OPY
OPY Financial Statistics
Sales & Book Value
Annual Sales: | $1.2B |
---|---|
Cash Flow: | $11.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $81.10 |
Price / Book: | 0.77 |
Profitability
EPS (TTM): | 6.43000 |
---|---|
Net Income (TTM): | $71.9M |
Gross Margin: | $441.5M |
Return on Equity: | 8.89% |
Return on Assets: | 2.29% |
Oppenheimer Holdings Earnings Forecast
Key Oppenheimer Holdings Financial Ratios
-
The Gross Profit Margin over the past 14 years for OPY is 35.35%.
-
The Selling, General & Administrative Expenses for OPY have been equal to 12.60% of Gross Profit Margin.
-
The Interest Expense is 227.31% of Operating Income.
-
The Net Earning history of OPY is 2.42% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 22 years.
Oppenheimer Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | OPY |
CUSIP: | 683797 |
Website: | oppenheimer.com |
Debt
Debt-to-Equity Ratio: | 0.73 |
---|---|
Current Ratio: | 5.21 |
Quick Ratio: | 3.41 |
Price-to-Earnings
Trailing P/E Ratio: | 24.11 |
---|---|
Forward P/E Ratio: | 0 |
OPY Technical Analysis vs Fundamental Analysis
Buy
63
Oppenheimer Holdings (OPY)
is a Buy
Is Oppenheimer Holdings a Buy or a Sell?
-
Oppenheimer Holdings stock is rated a BuyThe current Oppenheimer Holdings [OPY] share price is $62.45. The Score for OPY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.